Health Care: Drugs

Valeant Pharmaceuticals International Inc (VRX: NYSE)

$202.02 -8.4 | -3.99%
04/27/15 - 04:01 PM ET
Company Profile
Price and Volume
Recent Price 210.42
52 Week High 211.57
52 Week Low 106.00
Avg. Daily Vol. (Mil) 2.86
Beta (3 year) 0.85
Share Related Items
Mkt Cap (Mil) 70,486.14
Shares Out (Mil) 336.20
Float (Mil) 273.13
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.90
Current Ratio 1.50
LT Debt/ Equity 2.87
Total Debt / Equity 2.87
Valuation Ratios
Price Earnings 78.70
Price/Sales 8.56
Price/Book 13.32
Price/Cash Flow 26.00
Per Share Data
Earnings 2.67
Sales 24.58
Book Value 15.80
Cash Flow 8.09
Business Summary
Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company that develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.
General Information
2150 Street Elzar Boulevard
Laval, QC H7L 4A8
Industry : Drugs
Sector: Health Care
Employees: 16800
CEO: J. Michael Pearson
Short Interest
Current Month (Mil) 6.46
Previous Month (Mil) 6.12
Short Interest Ratio (Days) 3.90
Management Effectiveness
Return on Equity 17.20
Return on Assets 3.50
Return on Investments 4.40
Gross Margin 75.80
EBIT Margin 25.00
Profit Margin 11.00

Portfolios with VRX

Latest VRX Headlines from TheStreet

More Financial News for VRX

Press Releases for VRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter